Weather Alert  

FLASH FLOOD WATCH REMAINS IN EFFECT FROM THIS EVENING THROUGH TUESDAY AFTERNOON CCA The Flash Flood Watch continues for * Portions of southern Connecticut, northeast New Jersey and southeast New York, including the following areas, in southern Connecticut, Northern Fairfield, Northern Middlesex, Northern New Haven, Northern New London, Southern Fairfield, Southern Middlesex, Southern New Haven and Southern New London. In northeast New Jersey, Eastern Bergen, Eastern Essex, Eastern Passaic, Eastern Union, Hudson, Western Bergen, Western Essex, Western Passaic and Western Union. In southeast New York, Bronx, Kings (Brooklyn), New York (Manhattan), Northeast Suffolk, Northern Nassau, Northern Queens, Northern Westchester, Northwest Suffolk, Orange, Putnam, Richmond (Staten Island), Rockland, Southeast Suffolk, Southern Nassau, Southern Queens, Southern Westchester and Southwest Suffolk. * From this evening through Tuesday afternoon. * A rapidly developing low pressure system south of Long Island will likely produce heavy rainfall across the region. Rainfall totals of 2 to 4 inches with locally higher amounts are possible. Rainfall rates may exceed one inch per hour at times. * Heavy rain may produce areas of flash flooding.

Antibiotics may prevent second heart attack

LongIsland.com

Treatment with antibiotics may reduce the risk of heart attack and chest pain in some patients with heart disease, according to the results of a new study. In a study of 148 patients who experienced ...

Print Email

Treatment with antibiotics may reduce the risk of heart attack and chest pain in some patients with heart disease, according to the results of a new study.

In a study of 148 patients who experienced a heart attack or an episode of severe, heart-related chest pain, those who took a 3-month course of the antibiotic clarithromycin were 41% less likely to have another cardiovascular "event" during the next year and a half than patients who received an inactive (placebo) pill.

"Antibiotics seem to be a beneficial option" for patients with coronary heart disease, the study's lead author, Dr. Juha Sinisalo of Helsinki University Central Hospital in Finland, told Reuters Health.

But the Finnish researcher cautioned that the results are preliminary. "Larger studies are needed before this treatment can be justified for routine use," Sinisalo said.

One potential problem with using antibiotics to treat heart attack patients is that such widespread use of the drugs could increase the rate at which bacteria become resistant to antibiotics, Sinisalo noted. If antibiotics were to be used to treat heart attack in large numbers of people, "it would be better to limit the use to one certain group of antibiotics," according to Sinisalo. Widespread use of several different types of antibiotics could lead to more antibiotic resistance, the researcher explained.

Inflammation plays a role in both heart attacks and unstable angina, a type of heart-related chest pain that occurs when a person is at rest. Recently, more and more attention has been paid to the idea that infections may contribute to this inflammation.

Based on the potential link between infections and the inflammation involved in heart disease, investigators have tried to find out whether clearing infections with antibiotics can benefit heart disease patients. So far, the results of these studies have not been conclusive.

Unlike other studies that tested the effectiveness of short-term antibiotic treatment, Sinisalo's team evaluated the effects of a 3-month course of the antibiotic clarithromycin. The study included patients who had had a severe heart attack or unstable angina. The findings will be published in the April 2nd issue of Circulation: Journal of the American Heart Association.

Patients treated with the antibiotic were 41% less likely to have another heart attack, unstable angina or other type of cardiovascular event. The apparent beneficial effect of clarithromycin began while patients were taking the drug, but this effect did not diminish after the patients stopped taking it.

The researchers suspect that most of the benefits were due to clarithromycin's antibacterial effect. They note that a bacterium called Chlamydia pneumoniae, which is targeted by clarithromycin, can produce inflammation in blood vessels. But the authors point out that clarithromycin may have affected other infections, too. In addition, the antibiotic has a direct anti-inflammatory effect, which could have accounted for some of the benefits, they note.

SOURCE: Circulation 2002;105.